| Louis H Tiger, MD | |
|
566 Broadway, Massapequa, NY 11758 | |
| (516) 541-6262 | |
| (516) 541-0011 |
| Full Name | Louis H Tiger |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 566 Broadway, Massapequa, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902960891 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 103799 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Louis H Tiger, MD 566 Broadway, Massapequa, NY 11758-5017 Ph: (516) 541-6262 | Louis H Tiger, MD 566 Broadway, Massapequa, NY 11758 Ph: (516) 541-6262 |
News Archive
The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature-a crucial prerequisite for life-saving therapies-has proven far more difficult.
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.
As part of its continued commitment to ADHD research, Shire plc, the global specialty biopharmaceutical company, today announced it is initiating two Phase 4 clinical trials to compare Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) to Concerta (methylphenidate HCl) Extended-Release Tablets.
Portuguese scientists identified a molecular mechanism that can lead to metastases (spread of the cancer from the original site to other remote parts of the body) in breast cancers. Abnormally high levels of P-cadherin - an adhesion molecule that enables cells to bind together - occur in about a third of all breast cancers and are associated with poor prognosis.
› Verified 7 days ago
Dr. Roger Kersten, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 510 Hicksville Rd, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Miloni H Thakker, Rheumatology Medicare: Medicare Enrolled Practice Location: 1061 N Broadway Ste 2, Massapequa, NY 11758 Phone: 631-758-7003 | |
David Alan Goldstein, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 510 Hicksville Road, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Dr. Grigoriy Krichmar, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 510 Hicksville Rd, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Michael Falkove, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 4150 Sunrise Hwy, Massapequa, NY 11758 Phone: 516-541-1721 Fax: 516-541-1463 | |
Dr. Conan Tu, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4150 Sunrise Hwy, Massapequa, NY 11758 Phone: 516-541-1721 Fax: 516-541-1463 | |
Dr. Herbert I. Pasternak, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 187 Veterans Blvd, Massapequa, NY 11758 Phone: 516-795-5523 Fax: 516-795-5521 |